Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hess

Showing results (671-680 of 690) with videos related to

Pageof 69
Sort By:
Science (New York, N.Y.)|December 21, 2013
Order of magnitude smaller limit on the electric dipole moment of the electron, J Baron, W C Campbell, et al.
JCI Insight|March 24, 2025
Altered chaperone-nonmuscle myosin II interactions drive pathogenicity of the UNC45A c.710T>C variant in osteo-oto-hepato-enteric syndromeStephanie Waich, Karin Kreidl, Julia Vodopiutz, et al.
Cells|October 23, 2021
The SZT2 Interactome Unravels New Functions of the KICSTOR ComplexCecilia Cattelani, Dominik Lesiak, Gudrun Liebscher, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 1, 2021
Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson's Disease: A Placebo-Controlled Trial of RasagilineDavid J Arpin, Trina Mitchell, Derek B Archer, et al.
Movement Disorders Clinical Practice|June 10, 2026
Determinants of Deep Brain Stimulation Candidacy Failure in Movement Disorders: A Multidisciplinary AnalysisPatricia J Graese, Hikaru Kamo, Kelly D Foote, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2015
An inducible mouse model for microvillus inclusion disease reveals a role for myosin Vb in apical and basolateral traffickingKerstin Schneeberger, Georg F Vogel, Hans Teunissen, et al.
Nature Genetics|August 30, 2008
MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarityThomas Müller, Michael W Hess, Natalia Schiefermeier, et al.
Plos One|August 23, 2012
A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulationMichelle L Scalley-Kim, Bruce W Hess, Ryan L Kelly, et al.
Human Mutation|February 27, 2010
Loss-of-function of MYO5B is the main cause of microvillus inclusion disease: 15 novel mutations and a CaCo-2 RNAi cell modelFrank M Ruemmele, Thomas Müller, Natalia Schiefermeier, et al.
Cardiovascular Research|August 15, 2019
miR-19a-3p containing exosomes improve function of ischaemic myocardium upon shock wave therapyCan Gollmann-Tepeköylü, Leo Pölzl, Michael Graber, et al.
Pageof 69

Showing results (671-680 of 690) with videos related to

Sort By:
Pageof 69
Science (New York, N.Y.)|December 21, 2013
Order of magnitude smaller limit on the electric dipole moment of the electron, J Baron, W C Campbell, et al.
JCI Insight|March 24, 2025
Altered chaperone-nonmuscle myosin II interactions drive pathogenicity of the UNC45A c.710T>C variant in osteo-oto-hepato-enteric syndromeStephanie Waich, Karin Kreidl, Julia Vodopiutz, et al.
Cells|October 23, 2021
The SZT2 Interactome Unravels New Functions of the KICSTOR ComplexCecilia Cattelani, Dominik Lesiak, Gudrun Liebscher, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 1, 2021
Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson's Disease: A Placebo-Controlled Trial of RasagilineDavid J Arpin, Trina Mitchell, Derek B Archer, et al.
Movement Disorders Clinical Practice|June 10, 2026
Determinants of Deep Brain Stimulation Candidacy Failure in Movement Disorders: A Multidisciplinary AnalysisPatricia J Graese, Hikaru Kamo, Kelly D Foote, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2015
An inducible mouse model for microvillus inclusion disease reveals a role for myosin Vb in apical and basolateral traffickingKerstin Schneeberger, Georg F Vogel, Hans Teunissen, et al.
Nature Genetics|August 30, 2008
MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarityThomas Müller, Michael W Hess, Natalia Schiefermeier, et al.
Plos One|August 23, 2012
A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulationMichelle L Scalley-Kim, Bruce W Hess, Ryan L Kelly, et al.
Human Mutation|February 27, 2010
Loss-of-function of MYO5B is the main cause of microvillus inclusion disease: 15 novel mutations and a CaCo-2 RNAi cell modelFrank M Ruemmele, Thomas Müller, Natalia Schiefermeier, et al.
Cardiovascular Research|August 15, 2019
miR-19a-3p containing exosomes improve function of ischaemic myocardium upon shock wave therapyCan Gollmann-Tepeköylü, Leo Pölzl, Michael Graber, et al.
Pageof 69